Physician profile
Thomas D Kim
NPI 1760530786
$5,103.06
in general payments reported to CMS, 2019-2025
13 companies · $207 in 2025
The $207 reported for 2025 was more than what 77% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,256 · 2020: $568 · 2021: $515 · 2022: $822 · 2023: $759 · 2024: $976 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,738 · Travel and Lodging: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,737.75 |
| Travel and Lodging | $203.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,899.17 | 2019-2025 | Aveir, Mitraclip, Cardiomems |
| Medtronic Vascular, INC. | $1,054.70 | 2019-2020 | |
| Edwards Lifesciences Corporation | $301.70 | 2019-2024 | Pascal, Evoque, Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $208.85 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $168.37 | 2023 | Optimizer |
| Biotronik INC. | $123.59 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $119.69 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $118.25 | 2024 | Camzyos |
| Hologic Sales and Service, LLC | $32.56 | 2024 | Aptima |
| Dexcom, INC. | $27.71 | 2025 | Dexcom G6 Transmitter |
| Teleflex LLC | $20.65 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.42 | 2021 | |
| Medtronic, INC. | $12.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.